Our study found that CM patients in the low-cTMGs subgroup were predominantly distributed in the “immune” cluster, whereas the remaining patients were largely in the “keratin” and “MITF-low” clusters (Figure 4C). The gene discussed is MITF; the disease is cutaneous mastocytosis.